delta-8-tetrahydrocannabinol
Term · Oncology and biomedicine · MLC-T-ONC-012956
An analogue of tetrahydrocannabinol (THC), with potential antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective activities. Delta-8-tetrahydrocannabinol (delta-8-THC) binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system; CB1 receptor activation may inhibit adenyl cyclase, increase mitogen-activated protein kinase activities, modulate several potassium channel conductances and inhibit N- and P/Q-type Ca2+ channels. This agent exhibits a lower psychotropic potency than delta-9-tetrahydrocannabinol (delta-9-THC), the primary form of THC found in cannabis.
| Identifier | MLC-T-ONC-012956 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | delta-8-THC |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012956",
"term": "delta-8-tetrahydrocannabinol",
"field": "Oncology and biomedicine",
"definition": "An analogue of tetrahydrocannabinol (THC), with potential antiemetic, anxiolytic, appetite-stimulating, analgesic, and neuroprotective activities. Delta-8-tetrahydrocannabinol (delta-8-THC) binds to the cannabinoid G-protein coupled receptor CB1, located in the central nervous system; CB1 receptor activation may inhibit adenyl cyclase, increase mitogen-activated protein kinase activities, modulate several potassium channel conductances and inhibit N- and P/Q-type Ca2+ channels. This agent exhibits a lower psychotropic potency than delta-9-tetrahydrocannabinol (delta-9-THC), the primary form of THC found in cannabis.",
"abbreviation": "delta-8-THC",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/delta-8-tetrahydrocannabinol/"
}
Record 5,795 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.